Lori Wood

发表

A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195

E. Eisenhauer, J. Squire, S. Sridhar, 2015, Investigational New Drugs.

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.

C. Bokemeyer, K. Oechsle, F. Mayer, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.